TFIPS
ADMA icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s ADMA Biologics ADMA Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-67,500
Closed -$108K – 390
2021
Q2 		$108K Hold
67,500
– – 0.13% 84
2021
Q1 		$119K Buy
+67,500
New +$154K 0.17% 76

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's ADMA Position: Q3 2021 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA sold out of ADMA Biologics (ADMA) in Q3 2021, closing a stake of 67,500 shares — an estimated $108K sold.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ADMA in Q1 2021 and held it in 2 quarters. The position peaked at $119K in Q1 2021. 72 funds tracked by Wall St. Rank hold ADMA as of Q3 2021.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA reported no remaining ADMA Biologics position as of Q3 2021 after selling out during the quarter.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 67,500 ADMA Biologics shares in Q3 2021, an estimated $108K.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ADMA Biologics in Q1 2021 and held it in 2 quarters.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's ADMA Biologics position peaked at $119K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2021.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q3 2021, filed 14 Aug 2025.